Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mucin 1-mediated chemo-resistance in lung cancer cells
Sun-Young Ham, Il Keun Kwon, Y BAK, et al.
Oncogenesis (2016) Vol. 5, Iss. 1, pp. e185-e185
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer
Santanu Maji, Sanjay Panda, Sabindra K. Samal, et al.
Advances in cancer research (2017), pp. 37-75
Closed Access | Times Cited: 184
Breast Cancer-Derived Exosomes Alter Macrophage Polarization via gp130/STAT3 Signaling
Sunyoung Ham, Luize Goncalves Lima, Edna Pei Zhi Chai, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 163
The Role of MUC1 in Renal Cell Carcinoma
Martina Milella, Monica Rutigliano, Francesco Lasorsa, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 315-315
Open Access | Times Cited: 34
Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway
Jian-Guo Ren, Pankaj Seth, Huihui Ye, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 117
Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
Tomas Koltai, Stephan J. Reshkin, Tiago M. A. Carvalho, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2486-2486
Open Access | Times Cited: 68
MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma
Hongyu Xu, Zedong Du, Zhihui Li, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 12
MUC1-C drives MYC in multiple myeloma
Ashujit Tagde, Hasan Rajabi, Audrey Bouillez, et al.
Blood (2016) Vol. 127, Iss. 21, pp. 2587-2597
Open Access | Times Cited: 75
microRNA: The Impact on Cancer Stemness and Therapeutic Resistance
Xueqiao Jiao, Xianling Qian, Longyuan Wu, et al.
Cells (2019) Vol. 9, Iss. 1, pp. 8-8
Open Access | Times Cited: 55
The role of mucin 1 in respiratory diseases
Beatriz Ballester, Javier Milara, Julio Cortijo
European Respiratory Review (2021) Vol. 30, Iss. 159, pp. 200149-200149
Open Access | Times Cited: 44
Radiotherapy/Chemotherapy-Immunotherapy for Cancer Management: From Mechanisms to Clinical Implications
Qian Li, Lei Xu, Jing Zhu, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-9
Open Access | Times Cited: 21
Epithelial–mesenchymal transition to Mitigate Age-Related Progression in Lung Cancer
Riya Thapa, Saurabh Gupta, Gaurav Gupta, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102576-102576
Closed Access | Times Cited: 8
Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments
Anusha Pusuluri, Debra Wu, Samir Mitragotri
Journal of Controlled Release (2019) Vol. 305, pp. 130-154
Closed Access | Times Cited: 53
Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance
Hongmei Cui, Kinsie E. Arnst, Duane D. Miller, et al.
Current Medicinal Chemistry (2020) Vol. 27, Iss. 39, pp. 6573-6595
Closed Access | Times Cited: 50
MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells
Hyebin Koh, Hyeri Park, Nisansala Chandimali, et al.
Oncotarget (2017) Vol. 8, Iss. 66, pp. 110540-110551
Open Access | Times Cited: 41
MUC1 Drives the Progression and Chemoresistance of Clear Cell Renal Carcinomas
Emma Bourdon, Thomas Swierczewski, Marine Goujon, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 391-391
Open Access | Times Cited: 4
The effects of anticancer medicinal herbs on vascular endothelial growth factor based on pharmacological aspects: a review study
Sajad Fakhri, Fatemeh Abbaszadeh, Masoumeh Jorjani, et al.
Nutrition and Cancer (2019) Vol. 73, Iss. 1, pp. 1-15
Closed Access | Times Cited: 30
Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression
Saravanakumar Marimuthu, Sanchita Rauth, Koelina Ganguly, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 2, pp. 575-588
Open Access | Times Cited: 26
Abnormal Glycosylation of Cancer Stem Cells and Targeting Strategies
Thahomina Khan, Horacio Cabral
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
Dual Approaches in Oncology: The Promise of siRNA and Chemotherapy Combinations in Cancer Therapies
Carolina Sousa, Mafalda Videira
Onco (2025) Vol. 5, Iss. 1, pp. 2-2
Open Access
Transmembrane mucins in lung adenocarcinoma: understanding of current molecular mechanisms and clinical applications
Xiaoqing Li, Ying Chen, Rui Lan, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells
Nisansala Chandimali, Do Luong Huynh, Jiaojiao Zhang, et al.
Cancer Gene Therapy (2018) Vol. 26, Iss. 9-10, pp. 292-304
Open Access | Times Cited: 32
Promotion of tumor progression and cancer stemness by MUC15 in thyroid cancer via the GPCR/ERK and integrin-FAK signaling pathways
Cheol-Won Choi, Nguyen Thi Thao Tran, Van Ngu Trinh, et al.
Oncogenesis (2018) Vol. 7, Iss. 11
Open Access | Times Cited: 32
EGFR and Prion protein promote signaling via FOXO3a‐KLF5 resulting in clinical resistance to platinum agents in colorectal cancer
Caroline Atkinson, Futoshi Kawamata, Cheng Liu, et al.
Molecular Oncology (2018) Vol. 13, Iss. 4, pp. 725-737
Open Access | Times Cited: 32
Correlation between mucin biology and tumor heterogeneity in lung cancer
Menglin Xu, Diane C. Wang, Xiangdong Wang, et al.
Seminars in Cell and Developmental Biology (2016) Vol. 64, pp. 73-78
Closed Access | Times Cited: 29
MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy
Chameli Ratan, Dalia Cicily K. D, Bhagyalakshmi Nair, et al.
Current Cancer Drug Targets (2020) Vol. 21, Iss. 2, pp. 132-152
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top